A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT) (SCRIPT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00476996
Recruitment Status : Active, not recruiting
First Posted : May 22, 2007
Last Update Posted : May 18, 2018
Roche Pharma AG
Information provided by (Responsible Party):
Genentech, Inc.